Search results
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman. He was convicted of financial crimes for which he served over six years in federal prison and was fined over 70 million dollars.
Jan 14, 2022 · Martin Shkreli, the former pharmaceutical executive best known for unapologetically hiking the price of a lifesaving medication, must pay $64.6 million and will be barred for life from the drug...
May 19, 2022 · Martin Shkreli, a former pharmaceutical executive known for raising the price of a life-saving drug by 5,000%, was released from prison and transferred Wednesday to community confinement, the...
Jan 14, 2022 · Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge...
Jan 14, 2022 · Martin Shkreli, the former drug firm executive who ordered dramatic price hikes of a life-saving medicine, has been barred from the industry for life. In a decision on Friday, Judge Denise Cote...
May 18, 2022 · Martin Shkreli, the former pharmaceutical executive known for raising the price of a lifesaving drug more than 40-fold, has been released from prison, where he had been serving a seven-year term...
Mar 9, 2018 · Martin Shkreli, a former pharmaceutical executive notorious for sharply increasing drug prices, mounting sneering defenses of his actions and even issuing a bounty for one of Hillary Clinton’s...
Mar 9, 2018 · Shkreli, a Former Hedge Fund Manager and CEO of a Biopharmaceutical Company, Defrauded Investors and Engaged in Stock Fraud Scheme Involving Publicly Traded Retrophin Inc.
May 18, 2022 · Former drug firm executive Martin Shkreli, who became infamous for ordering dramatic price hikes of a life-saving medicine, has been released early from prison. Shkreli was serving a seven year...
Jan 23, 2024 · Today, the United States Court of Appeals for the Second Circuit affirmed a district court ruling which ordered “Pharma Bro” Martin Shkreli to face a lifetime ban from participating in the pharmaceutical industry and found Shkreli liable for $64.6 million in disgorgement for his role in orchestrating an illegal anticompetitive scheme.
